Press Releases

Press Releases

Ensysce Biosciences is pleased to announce the treatment of the first two patients with PF614, a two-step extended-release oxycodone prodrug designed to have abuse deterrent properties that limit its use to oral administration. The trial “A Phase 1, Single-Center, Dose-Escalation Study to Determine the Safety and Pharmacokinetics of a Single…

Press Releases

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous system (CNS) disorders, today announced the initiation of CLARITY, a Phase II study to evaluate pimavanserin for adjunctive treatment in patients with major depressive disorder (MDD) who have an inadequate response to…

Press Releases

Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced a long-term collaboration aimed at improving the bioavailability, efficacy and safety profile of oral therapeutic medicines through nanotechnology. Potential benefits of research in this area include a reduction of adverse effects, increased patient adherence to treatment and more convenient dosing. From 2017,…

Press Releases

Evotec AG announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine Merck's portfolio of genome editing technologies with Evotec's versatile screening platforms and disease expertise. Evotec will leverage Merck's comprehensive collection of genetic reagents such as viral CRISPR and shRNA…

Press Releases

Sosei Group Corporation announces that Heptares Therapeutics, the wholly-owned subsidiary of Sosei, has signed a share purchase agreement that will allow the acquisition of 100% in G7 Therapeutics, a privately held drug discovery and development company based in Switzerland, for CHF 12 million cash. The strategic acquisition broadens and strengthens…

Press Releases

Onxeo S.A., a biopharmaceutical company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announced having received communication from the European Patent Office (EPO) informing its intention to grant a new patent covering especially the particular nucleic acid molecule comprised within…

Press Releases

Mylan N.V. announced that the company has signed an agreement with the Medicines Patent Pool (MPP) to expand access to chronic hepatitis C medicines in developing countries. The agreement licenses Mylan to produce and market a generic version of Bristol-Myers Squibb's DAKLINZA™ (daclatasvir) Tablets, 30 mg and 60 mg, for…

Press Releases

Intec Pharma Ltd., a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces it has entered into an agreement with the Michael J. Fox Foundation for Parkinson's Research (MJFF) to support patient recruitment and retention support for the Intec Pharma's pivotal Phase…

Press Releases

Having the right contacts and a good network are indispensible in the business world. To help exhibitors and visitors make business contacts that suit them to a tee, for the first time ever analytica 2017 will feature a platform for pre-arranged meetings at a Buyer-Seller Forum. Vietnam's leading trade fair…

Press Releases

Research and Markets has announced the addition of the "Drug Discovery Technology Subscription" newsletter to their offering. The Drug Discovery Technology (DDT) Alert is Technical Insights' new technology research subscription that reports and analyzes the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights…